Total Payments
$361,405
2024 Payments
$38,330
Companies
46
Transactions
1,683
Medicare Patients
8,376
Medicare Billing
$8.4M
Payment Breakdown by Category
Other$236,788 (65.5%)
Travel$54,508 (15.1%)
Food & Beverage$35,516 (9.8%)
Consulting$34,109 (9.4%)
Education$483.93 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $232,723 | 102 | 64.4% |
| Travel and Lodging | $54,508 | 117 | 15.1% |
| Food and Beverage | $35,516 | 1,433 | 9.8% |
| Consulting Fee | $34,109 | 9 | 9.4% |
| Honoraria | $4,065 | 2 | 1.1% |
| Education | $483.93 | 20 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $79,841 | 214 | $0 (2024) |
| Amgen Inc. | $68,759 | 266 | $0 (2024) |
| GlaxoSmithKline, LLC. | $66,266 | 112 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $49,540 | 85 | $0 (2024) |
| PFIZER INC. | $40,139 | 160 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $23,128 | 50 | $0 (2020) |
| GENZYME CORPORATION | $16,812 | 30 | $0 (2024) |
| ABBVIE INC. | $4,940 | 216 | $0 (2024) |
| Janssen Biotech, Inc. | $2,089 | 132 | $0 (2024) |
| Nuvectra Corporation | $1,816 | 4 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $38,330 | 237 | Amgen Inc. ($22,761) |
| 2023 | $78,922 | 275 | Amgen Inc. ($38,545) |
| 2022 | $57,225 | 230 | Aurinia Pharma U.S., Inc. ($19,576) |
| 2021 | $39,872 | 217 | GlaxoSmithKline, LLC. ($17,113) |
| 2020 | $13,363 | 120 | Novartis Pharmaceuticals Corporation ($11,079) |
| 2019 | $62,031 | 211 | Novartis Pharmaceuticals Corporation ($19,653) |
| 2018 | $43,754 | 234 | Novartis Pharmaceuticals Corporation ($20,681) |
| 2017 | $27,907 | 159 | Novartis Pharmaceuticals Corporation ($11,664) |
All Payment Transactions
1,683 individual payment records from CMS Open Payments — Page 1 of 68
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Amgen Inc. | TAVNEOS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: Inflammation | ||||||
| 12/17/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Endocrinology | ||||||
| 12/16/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Inflammation | ||||||
| 12/13/2024 | Amgen Inc. | TAVNEOS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: Inflammation | ||||||
| 12/11/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Bone Health | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Dermatology | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.97 | General |
| Category: Immunology | ||||||
| 12/09/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2024 | GENZYME CORPORATION | KEVZARA (Biological) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Rheumatology | ||||||
| 12/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $28.66 | General |
| Category: Inflammation | ||||||
| 12/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $31.27 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/25/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Amgen Inc. | TAVNEOS (Drug) | Travel and Lodging | In-kind items and services | $559.59 | General |
| Category: Inflammation | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.92 | General |
| Category: Immunology | ||||||
| 11/19/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: Immunology | ||||||
| 11/18/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/18/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $2.93 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/14/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Travel and Lodging | Cash or cash equivalent | $207.70 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 11/14/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: Inflammation | ||||||
| 11/12/2024 | Octapharma USA, Inc. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Biological) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $11.40 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,955 | 233,917 | $6.2M | $2.3M |
| 2022 | 26 | 2,247 | 216,206 | $6.8M | $2.4M |
| 2021 | 24 | 1,950 | 150,469 | $5.1M | $2.0M |
| 2020 | 21 | 2,224 | 116,905 | $4.5M | $1.8M |
Total Patients
8,376
Total Services
717,497
Medicare Billing
$8.4M
Procedure Codes
93
All Medicare Procedures & Services
93 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3262 | Injection, tocilizumab, 1 mg | Office | 2023 | 26 | 136,568 | $1.2M | $619,919 | 50.4% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 23 | 14,525 | $1.6M | $489,205 | 30.6% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2023 | 38 | 33,226 | $1.4M | $338,627 | 24.9% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 152 | 16,080 | $578,880 | $294,735 | 50.9% |
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2023 | 21 | 24,990 | $349,860 | $199,765 | 57.1% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2023 | 17 | 4,430 | $509,450 | $116,361 | 22.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 648 | 1,245 | $242,775 | $109,580 | 45.1% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 56 | 369 | $102,582 | $35,873 | 35.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 174 | 174 | $42,978 | $21,419 | 49.8% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 87 | 412 | $58,916 | $20,057 | 34.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 74 | 89 | $12,193 | $5,532 | 45.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 62 | 96 | $11,808 | $4,756 | 40.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 177 | 404 | $11,312 | $4,415 | 39.0% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 30 | 188 | $11,468 | $4,054 | 35.3% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 104 | 104 | $7,696 | $3,802 | 49.4% |
| 76881 | Complete ultrasound scan of joint | Office | 2023 | 101 | 231 | $30,261 | $1,787 | 5.9% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2023 | 27 | 135 | $20,250 | $857.56 | 4.2% |
| 20600 | Aspiration and/or injection of fluid from small joint | Office | 2023 | 17 | 21 | $2,184 | $816.65 | 37.4% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 12 | 61 | $2,135 | $713.06 | 33.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 85 | 504 | $2,016 | $397.53 | 19.7% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2023 | 12 | 32 | $384.00 | $138.13 | 36.0% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2023 | 12 | 33 | $66.00 | $26.89 | 40.7% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2022 | 24 | 15,505 | $1.7M | $538,812 | 31.6% |
| J3262 | Injection, tocilizumab, 1 mg | Office | 2022 | 25 | 116,897 | $1.1M | $516,718 | 49.1% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2022 | 34 | 29,039 | $1.2M | $341,732 | 28.7% |
About Dr. Brian Kirby, M.D
Dr. Brian Kirby, M.D is a Rheumatology healthcare provider based in Pensacola, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1588751473.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Kirby, M.D has received a total of $361,405 in payments from pharmaceutical and medical device companies, with $38,330 received in 2024. These payments were reported across 1,683 transactions from 46 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($232,723).
As a Medicare-enrolled provider, Kirby has provided services to 8,376 Medicare beneficiaries, totaling 717,497 services with total Medicare billing of $8.4M. Data is available for 4 years (2020–2023), covering 93 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Pensacola, FL
- Active Since 10/10/2006
- Last Updated 04/18/2012
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1588751473
Products in Payments
- COSENTYX (Biological) $72,518
- BENLYSTA (Biological) $66,240
- TAVNEOS (Drug) $60,007
- LUPKYNIS (Drug) $49,540
- XELJANZ (Drug) $39,846
- KEVZARA (Biological) $20,938
- KEVZARA (Drug) $6,515
- NO PRODUCT DISCUSSED (Drug) $6,467
- Tavneos (Drug) $5,056
- KEVZARA SARILUMAB INJECTION (Biological) $3,864
- RINVOQ (Biological) $1,906
- Algovita (Device) $1,816
- Enbrel (Biological) $1,585
- Cimzia (Drug) $1,517
- COSENTYX (Drug) $1,253
- EVENITY (Biological) $1,183
- TREMFYA (Drug) $1,131
- SKYRIZI (Biological) $981.94
- ORENCIA (Biological) $821.42
- KRYSTEXXA (Biological) $818.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Pensacola
Dr. Michael Vandenberg, Md, MD
Rheumatology — Payments: $26,045
Rheumatology $26,045
Patricia Kachur
Rheumatology — Payments: $17,678
Rheumatology $17,678
Dr. Ellen Mcknight, Md, MD
Rheumatology — Payments: $11,383
Rheumatology $11,383
Dr. Nancy Morris, Md, MD
Rheumatology — Payments: $8,580
Rheumatology $8,580
Neilia-Kay Mcgill, Md, MD
Rheumatology — Payments: $8,574
Rheumatology $8,574
Dr. James Brown, Md, MD
Rheumatology — Payments: $5,760
Rheumatology $5,760